FLC fluence corporation limited

4.88%

3.9¢

The Nirobox family has also now been expanded and as such isn't...

First 35 Last

Share
Profile

Follow
Relax1

1,002 Posts.

3339

22/08/19

07:20

Post #: 40086568
Share

Originally posted by stockrock: ↑

I believe Nirobox's advantage is its small footprint (best in class), fast deployment (best in class), and low running costs (best in class). However, it is more expensive upfront than its competitors, as such BOOT is likely going to be the growth area in this space.

The recent Brazil desalination plant tender was a good example of the hurdles being faced when it comes to Nirobox sales ... Fluence had to choose between putting up a Nirobox solution to the customer or a custom engineered solution. Based on the customer's feedback during the tender process, it was made clear to Fluence that a Nirobox solution was too difficult to compare to all the other supplier's bids (who obviously all offered custom engineered solutions). As such, Fluence chose to compete head to head on the custom engineering solution because a 'off-the-shelf' solution was simply too difficult to comprehend and/or accept as a practical/workable solution to their water needs.

This is going to be a case-by-case proposition with Nirobox... you will have countries where the technology is embraced, like Egypt and/or island countries and resorts where land is scarce and/or require a quick desalination solution. And there will always be those who take longer to adopt new technology.

An interesting comment made by Adam in the Webinar he did with Canaccord. He said that they are bidding for 14/15 BOOT projects at the moment. And if they lowered their criteria for credit risk of their customers, they would be signing up plenty of BOOT projects and the US$50m facility would be used up very quickly. However, they are being very selective and ensuring that the customer's are able to pay for the water over the life of the contract (which can be up to 30 years).

In terms of Aspiral/SUBRE, there is a unique opportunity that essentially drove the merger in 2017. And that is China.

A lot of focus and resources poured into the success of Aspiral/SUBRE in China since the merger in mid 2017 ... and there is a very good reason why Henry keeps reiterating that the largest area for growth in the business is in China.

Incumbent water treatment technology is like a huge boulder that is extremely difficult to displace, however there is evidence that the boulder is shifting. And if Fluence are successful in displacing MBR as the preferred water treatment technology, then the opportunities are mind boggling.

State owned enterprises entering into multi-year purchases (iTEST - Aspiral) and leveraging off the advantages of MABR to achieve their own business growth objectives was an early indicator that we are on the right track. Provincial governments fitting new water treatment plants with MABR (SUBRE) is an indicator that MABR is starting to gain traction in China. Multi-year provincial government contracts for Aspiral will be confirmation that MABR's has been accepted as the replacement for MBR technology.

After that, it will be simply a matter of time before MABR is more widely adopted and becomes the go-to solution for water treatment.

Expand

The Nirobox family has also now been expanded and as such isn't even just desal or fresh water anymore, or in the case of Niroflex, isn't even containerized. Nirobox WW being MBR based is interesting, this family of products is unifying the range under one umbrella that is being offered in Argentina/Brazil, as they are MBR specialists there (with the traditional Israeli Nirobox suite). With this expansion in range under the Nirobox family, there is likely higher opportunity for the segment to have additional sales.

Nirobox SW - (Seawater, Reverse Osmosis).
Nirobox BW - (Brackish Water, Reverse Osmosis).
Nirobox FW - (Fresh Water, disc/ultrafiltration).

Niroplant - (modular Nirobox plants).
Nirosite - (modular Nirobox plants + centralized peripheral functions).

Niroflex - (skid-mounted treatment system, no shipping container, no cooling, cheaper option than Nirobox).

Ecobox - (water reuse/recycling, multi-system tertiary treatment train).

Nirobox WW - (MBR - membrane bio reactor based wastewater treatment system).

FLC Price at posting: 43.5¢ Sentiment: Buy Disclosure: Held
24 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 35 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change -0.002(4.88%)		Mkt cap ! $42.32M

Open	High	Low	Value	Volume
4.1¢	4.1¢	3.8¢	$17.54K	451.2K

Buyers (Bids)

No.	Vol.	Price($)
1	6812	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	161616	4

View Market Depth

No.	Vol.	Price($)
1	6812	0.039
1	13250	0.038
2	370000	0.037
1	350000	0.036
2	220000	0.035

Price($)	Vol.	No.
0.042	161616	4
0.043	120000	1
0.045	25000	1
0.047	2224	1
0.050	67600	1

Last trade - 15.51pm 27/06/2025 (20 minute delay)

FLC (ASX) Chart

The Nirobox family has also now been expanded and as such isn't...

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The Nirobox family has also now been expanded and as such isn't...

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News